2Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics.2002.CA Cancer J Clin,2005,55:74-108.
3Macura KJ.Multiparametric magnetic resonance imaging of the prostate:current status in prostate cancer detection,localization,and staging.Semin Roengenol,2008,43:303-313.
4Seitz M,Shukla-DaVe A,Bjartell A,et al.Functional magnetic resonance imaging in prostate cancer.Eur Urol,2009,55:801-814.
8Port RE,Knopp MV,Brix G.Dynamic contrast-enhanced MRI using Gd-DTPA:interindividual variability of the arterial input function and consequences fur the assessment of kinetics in tumors.Magn Reson Med,2001,45:1030-1038.
9Choyke PL,Dwyer AJ,Knopp MV.Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.J Magn Reson Imaging,2003,17:509-520.
10McMahon CJ,Bloch BN,Lenkinski RE,et al.Dynamic contrastenhanced MR imaging in the evaluation of patients with prostate cancer.Magn Reson Imaging Clin N Am,2009,17:363-383.
7Villeirs GM,Oosterlinck W,Vanherreweghe E,et al.A qualitative approach to combined magnetic resonance imaging and pectroscopy in the diagnosis of prostate cancer.Eur J Radiol,2008,10.[Epub ahead of print]
8De Matzo AM,DeWeese TL,Platz EA,et al.Pathological and molecular mechanisms of prostate carcinogenesis:implications for diagnosis,detection,prevention and treatment.J Cell Biochem,2004,91.:459-477.
9Kurhanewiez J,Vigneren DB,Hricak H,et al.Threedimensional H-I MR spectroscopic imaging of the in aitu human prostate with high (0.24-0.7 cm3) spatial resolution.Radiology,1996,198:795-805.
10Aekerstaff E,Pflug BR,Nelson JB,et al.Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent transformation of prostatic epithelial cells.Cancer Research,2001,61:3599-3603.
